Is ullipristal is available in india as a emergency contraceptive
Reading File
Finding Sources
Searching the Web
ulipristal acetate emergency contraceptive available India approved 2025 2026
Reading Web Page
ulipristal acetate India availability registered approved
Now I have a clear picture. Here is a thorough answer:
Ulipristal Acetate (UPA) as Emergency Contraception in India
Short answer: No, ulipristal acetate is NOT currently approved or marketed in India as an emergency contraceptive.
What the evidence shows
According to the ECEC global EC database (the most authoritative global registry of emergency contraceptive availability), India is not listed among the countries where UPA-based EC is registered or available - whether OTC, behind-the-counter, or by prescription. India does not appear in any UPA category on their list.
The GNH India page listing "Ella 30mg" is a pharmaceutical export/B2B supplier based in Mumbai - they deal in medicines sourced globally for international export, not domestic retail sale. This does NOT mean Ella is approved for sale in India to Indian consumers.
What IS available in India for emergency contraception
India's EC market uses:
- Levonorgestrel (LNG) 1.5 mg - the dominant EC option, sold OTC under brands like i-Pill, Unwanted-72, Preventol, NoWait, etc. Must be taken within 72 hours (most effective within 24 hours).
- Mifepristone 10-25 mg - available in some countries including India under prescription for EC, though primarily known as a medical abortion drug.
About Ulipristal - pharmacology for context
From Goodman & Gilman's Pharmacological Basis of Therapeutics and Lippincott Illustrated Reviews in Pharmacology:
- UPA (30 mg single dose, brand name Ella in the US/EU) is a selective progesterone receptor modulator (SPRM)
- Works up to 120 hours (5 days) post-unprotected intercourse - a key advantage over LNG
- Superior efficacy vs. LNG, especially between 72-120 hours
- FDA-approved in the US (2010); widely available in Europe and ~56+ other countries
- It works primarily by inhibiting or delaying ovulation
- Pregnancy rate: ~1.4% vs. ~2.2% with LNG (from meta-analyses in Kaplan & Sadock)
Why it's not available in India
India's drug regulatory body (CDSCO - Central Drugs Standard Control Organisation) has not approved ulipristal acetate as an EC. India's contraceptive regulatory landscape tends to lag behind Western approvals, and with LNG being cheap, widely available OTC, and embedded in public health programs, there has been limited commercial or regulatory push to introduce UPA.
Bottom line
| Drug | India availability | Window | OTC? |
|---|---|---|---|
| Levonorgestrel 1.5 mg | Yes - widely available | 72 hours | Yes |
| Ulipristal acetate 30 mg | No - not approved/marketed | 120 hours | N/A |
| Copper IUD | Yes (with provider) | 5 days | No |
If a patient needs EC beyond 72 hours in India, the copper IUD (inserted within 5 days) remains the most effective option available. Ulipristal in India would need to be the subject of a CDSCO approval process before it could be legally prescribed or dispensed.
This is a shared conversation. Sign in to Orris to start your own chat.